journal article·2018-04

Light‐Triggered Retention and Cascaded Therapy of Albumin‐Based Theranostic Nanomedicines to Alleviate Tumor Adaptive Treatment Tolerance

Jing Chen, Lu Liu, Seyed Mohammad Motevalli, Xiaoli Wu, Xiao‐Hong Yang, Xianlei Li, Lu Han, Andrea Magrini, Weisheng Guo, Jin Chang, Massimo Bottini, Xing‐Jie Liang

Advanced Functional Materials· Volume 28· Issue 17
Publisher page

Abstract

Abstract Tumor adaptive treatment tolerance associated with chemotherapy originates from low tumor accumulation and adverse effects and remains a formidable challenge for cancer therapy. Herein, human serum albumin (HSA)‐based nanomedicines modified with diazirine and loaded with indocyanine green (ICG) and tirapazamine (TPZ), denoted as ICG/TPZ@HSA dNMs are developed. The obtained ICG/TPZ@HSA dNMs can efficiently eradicate the tumors through a cascade of synergistic events triggered by the sequential irradiation of lasers in the tumor area. Upon a 405 nm laser irradiation, the ICG/TPZ@HSA dNMs are able to form aggregates via crosslinking and thus realized enhanced tumor site accumulation and prolonged retention time. The following irradiation at tumor area with an 808 nm laser‐generated local hyperthermia and reactive oxygen species, which results in efficient tumor ablation and increased local hypoxia in the tumor microenvironment. The resulted local hypoxia further activates the initially nontoxic TPZ to a highly cytotoxic derivative, by which precisely bioactivated chemotherapy is achieved following the phototherapy. Thus, upon the laser irradiations, a cascade of aggregation, phototherapy, and bioactivated chemotherapy is successfully triggered, which achieves efficient precise eradication of tumors without detectable side effects in vivo.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Life Sciences Tianjin University Tianjin Engineering Center of Micro Nano Biomaterials and Detection Treatment Technology Collaborative Innovation Center of Chemical Science and Engineering Tianjin 300072 P. R. China

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center for Excellence in Nanoscience National Center for Nanoscience and Technology of China Beijing 100190 P. R. China

Beijing Engineering Research Center of Printed Electronics Beijing Institute of Graphic Communication Beijing 102600 P. R. China

Department of Biopathology and Imaging Diagnostics University of Rome Tor Vergata Rome 00133 Italy

Department of Experimental Medicine and Surgery University of Rome Tor Vergata Rome 00133 Italy

Funding

National Natural Science Foundation of China · Chinese Academy of Sciences

References (44)

Show source-provided references
1. 10.1038/natrevmats.2017.2410.1038/natrevmats.2017.24 ↗
2. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
3. 10.1021/acsnano.6b0576010.1021/acsnano.6b05760 ↗
4. 10.1126/science.122633810.1126/science.1226338 ↗
5. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
6. 10.1021/nn505660r10.1021/nn505660r ↗
7. 10.1038/nmat379210.1038/nmat3792 ↗
8. 10.1021/ja401612x10.1021/ja401612x ↗
9. 10.1158/0008-5472.CAN-12-456110.1158/0008-5472.CAN-12-4561 ↗
10. 10.1021/acsnano.6b0872010.1021/acsnano.6b08720 ↗
11. 10.1038/nnano.2011.16610.1038/nnano.2011.166 ↗
12. 10.1038/nbt.333010.1038/nbt.3330 ↗
13. 10.1038/nnano.2015.34210.1038/nnano.2015.342 ↗
14. 10.1002/adma.20160489410.1002/adma.201604894 ↗
15. 10.1021/acs.nanolett.6b0257710.1021/acs.nanolett.6b02577 ↗
16. 10.1021/acsnano.7b0003810.1021/acsnano.7b00038 ↗
17. 10.1021/acs.nanolett.5b0434310.1021/acs.nanolett.5b04343 ↗
18. 10.1002/adma.20160592810.1002/adma.201605928 ↗
19. 10.1038/s41467-017-01599-w10.1038/s41467-017-01599-w ↗
20. 10.1038/ncomms1499810.1038/ncomms14998 ↗
21. 10.1038/s41467-017-01050-010.1038/s41467-017-01050-0 ↗
22. 10.1038/nrclinonc.2012.17110.1038/nrclinonc.2012.171 ↗
23. 10.1007/s10439-016-1578-610.1007/s10439-016-1578-6 ↗
24. 10.1016/j.addr.2015.10.02110.1016/j.addr.2015.10.021 ↗
25. 10.1200/JCO.2009.27.444910.1200/JCO.2009.27.4449 ↗
26. 10.1016/j.ijrobp.2009.04.01110.1016/j.ijrobp.2009.04.011 ↗
27. 10.1200/JCO.2001.19.2.53510.1200/JCO.2001.19.2.535 ↗
28. 10.1021/acsnano.6b0873110.1021/acsnano.6b08731 ↗
29. Qian C. · Angew. Chem., Int. Ed. · 2017 · 129 · 255810.1002/ange.201701131 ↗
30. Chen D. X. · Small · 2017 · 13 · 1605053
31. 10.1002/anie.20150981010.1002/anie.201509810 ↗
32. 10.1002/adma.20160386410.1002/adma.201603864 ↗
33. 10.1021/acsnano.6b0541910.1021/acsnano.6b05419 ↗
34. 10.1021/nn506238610.1021/nn5062386 ↗
35. 10.1021/jacs.5b0602510.1021/jacs.5b06025 ↗
36. 10.1021/acs.nanolett.7b0331010.1021/acs.nanolett.7b03310 ↗
37. 10.1002/anie.20150047810.1002/anie.201500478 ↗
38. 10.7150/thno.1936510.7150/thno.19365 ↗
39. 10.1002/adma.20170117010.1002/adma.201701170 ↗
40. 10.1021/nn506107c10.1021/nn506107c ↗
41. 10.1002/anie.20140218910.1002/anie.201402189 ↗
42. 10.1002/adma.20150586910.1002/adma.201505869 ↗
43. 10.1039/c1cs15077d10.1039/c1cs15077d ↗
44. 10.1002/anie.20130446510.1002/anie.201304465 ↗